Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
31. lappuse
... dilute hydrochloric acid ( 0.6 percent volume / volume ) ) . The dissolution appa- ratus used in these two methods differs significantly from the apparatus de- scribed in the method in the compen- dium . The Food and Drug Administra ...
... dilute hydrochloric acid ( 0.6 percent volume / volume ) ) . The dissolution appa- ratus used in these two methods differs significantly from the apparatus de- scribed in the method in the compen- dium . The Food and Drug Administra ...
303. lappuse
... dilute to 1,000 milliliters . ( ii ) The insulin solution . From a sam- ple of the zinc - insulin crystals to be used in making the batch weigh a quantity which contains 10,000 U.S.P. Units of insulin . Dissolve the crystals in 15 ...
... dilute to 1,000 milliliters . ( ii ) The insulin solution . From a sam- ple of the zinc - insulin crystals to be used in making the batch weigh a quantity which contains 10,000 U.S.P. Units of insulin . Dissolve the crystals in 15 ...
355. lappuse
... Diluting fluid A. Dissolve 1 gram of U.S.P. peptic digest of animal tissue or equivalent in suffi- cient distilled ... Diluting fluid B. To each liter of diluting fluid A add 5.0 milliliters of polysorbate 80 before sterilization . ( 3 ) ...
... Diluting fluid A. Dissolve 1 gram of U.S.P. peptic digest of animal tissue or equivalent in suffi- cient distilled ... Diluting fluid B. To each liter of diluting fluid A add 5.0 milliliters of polysorbate 80 before sterilization . ( 3 ) ...
371. lappuse
... dilute aliquots of the working standard stock solution with dimethylsulfoxide to give concentrations of 12.8 , 16 , 20.0 , 25 , and 31.2 micrograms per milliliter . 2 Further dilute aliquots of the working standard stock solution with ...
... dilute aliquots of the working standard stock solution with dimethylsulfoxide to give concentrations of 12.8 , 16 , 20.0 , 25 , and 31.2 micrograms per milliliter . 2 Further dilute aliquots of the working standard stock solution with ...
390. lappuse
... dilute to volume with water . Further dilute an accu- rately measured portion with distilled water to obtain a known concentration of 0.01 to 0.02 milligram of tetracycline hydrochloride per milliliter . ( ii ) Preparation of sample ...
... dilute to volume with water . Further dilute an accu- rately measured portion with distilled water to obtain a known concentration of 0.01 to 0.02 milligram of tetracycline hydrochloride per milliliter . ( ii ) Preparation of sample ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning